Cboe BZX · GNMX

Corgi Genomics & Precision Medicine ETF (GNMX)

$38.41+0.92%

Close Sep 29, 2026 · split-adjusted

Sep 29, 2026$38.41▲ 12.47% in range

Sep 11, 2026Low $34.15 · High $38.41Sep 29, 2026

What changed · written from our data

As of Sep 29, 2026

Corgi Genomics & Precision Medicine ETF closed at $38.41 on Sep 29, up 0.92% — matching its highest close since Dec 16. Volume of 495 shares was 0.55× its 20-day average (below normal).

Short interest was 667 shares at the Sep 15 settlement, down 89.0% from the prior report (1.0 days to cover).

Market cap—

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Dec 1634.15 – 38.410.0% from high

Volume4950.55× 20-day avg

Volatility · 60d—Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W +2.3%1M —3M —6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short667−89.0% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d72.2%of daily volume

News about Corgi Genomics & Precision Medicine ETF

All news →

No recent articles focused on Corgi Genomics & Precision Medicine ETF.

Quick answers

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology